| Target Price | $1,555.50 |
| Price | $1,029.00 |
| Potential | 51.17% |
| Number of Estimates | 47 |
| 47 Analysts have issued a price target Micron Technology 2027 . The average Micron Technology target price is $1,555.50. This is 51.17% higher than the current stock price. The highest price target is $2,100.00 104.08% , the lowest is $191.90 81.35% . | |
| A rating was issued by 58 analysts: 53 Analysts recommend Micron Technology to buy, 4 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Micron Technology stock has an average upside potential 2027 of 51.17% . Most analysts recommend the Micron Technology stock at Purchase. |
51 Analysts have issued a sales forecast Micron Technology 2027 . The average Micron Technology sales estimate is
This results in the following potential growth metrics:
34 Analysts have issued an Micron Technology EBITDA forecast 2027. The average Micron Technology EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
51 Micron Technology Analysts have issued a net profit forecast 2027. The average Micron Technology net profit estimate is
This results in the following potential growth metrics and future Net Margins:
51 Analysts have issued a Micron Technology forecast for earnings per share. The average Micron Technology EPS is
This results in the following potential growth metrics and future valuations:
Micron Technology...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| DA Davidson |
Buy
➜
Buy
|
Unchanged | Oct 01 2026 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Oct 01 2026 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Oct 01 2026 |
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Oct 01 2026 |
| Rosenblatt |
Buy
➜
Buy
|
Unchanged | Oct 01 2026 |
| Mizuho |
Outperform
➜
Outperform
|
Unchanged | Oct 01 2026 |
| Needham |
Buy
➜
Buy
|
Unchanged | Oct 01 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
DA Davidson:
Buy
➜
Buy
|
Oct 01 2026 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Oct 01 2026 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Oct 01 2026 |
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Oct 01 2026 |
|
Unchanged
Rosenblatt:
Buy
➜
Buy
|
Oct 01 2026 |
|
Unchanged
Mizuho:
Outperform
➜
Outperform
|
Oct 01 2026 |
|
Unchanged
Needham:
Buy
➜
Buy
|
Oct 01 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


